Parvovirus Infection Triggering Still’s Disease
  • Yaiza Altuzarra-Ranedo
    Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Clínico San Carlos, IdISCC, Spain
  • Daniel Gómez-Ramírez
    Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Clínico San Carlos, IdISCC, Spain
  • María Rodríguez-Laguna
    Servicio de Reumatología, Hospital Clínico San Carlos, Spain
  • Pía Mercedes Lois-Bermejo
    Servicio de Reumatología. Hospital Clínico San Carlos
  • Blanca López-Pelaez
    Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Clínico San Carlos, IdISCC, Spain
  • Noel Lorenzo-Villalba
    Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, France
  • Manuel Méndez-Bailón
    Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Clínico San Carlos, IdISCC, Spain

Keywords

Parvovirus B19, adult-onset Still's disease, systemic inflammatory response

Abstract

We present the case of a 59-year-old man with acute B19 parvovirus infection who developed a systemic inflammatory reaction similar to adult-onset Still's disease (AOSD). We discuss the clinical challenge due to overlapping symptoms to distinguish between a primary B19 viral infection and the autoimmune disease it can trigger.

VIEW THE ENTIRE ARTICLE

References

  • Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350(6):586–597.
  • Hayakawa H, Tara M, Niina K, Osame M. A clinical study of adult human parvovirus B19 infection. Intern Med 2002;41(4):295–299.
  • Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989;149(5):1153–1156.
  • Waza K, Inoue K, Matsumura S. Symptoms associated with parvovirus B19 infection in adults: a pilot study. Intern Med 2007;46(24):1975–1978.
  • Sève P, Ferry T, Koenig M, Cathebras P, Rousset H, Broussolle C. Lupus-like presentation of parvovirus B19 infection. Semin Arthritis Rheum 2005;34(4):642–648.
  • Meyer O. Parvovirus B19 and autoimmune diseases. Joint Bone Spine 2003;70(1):6–11.
  • Bultmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003;34:92–95.
  • Jia X, Gong L, Huang G, Zhang W. [Review of correlation between human parvovirus B19 and autoimmune disease etiology]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2020 Jan;36(1):75–80. [Article in Chinese]. PMID: 32314727.
  • Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol 2008;22(5):773–792.
  • Wouters JM, van der Veen J, van de Putte LB, de Rooij DJ. Adult onset Still’s disease and viral infections. Ann Rheum Dis 1988;47(9):764–767.
  • Ansell BM, Bywaters EG, Lawrence JS. Familial aggregation and twin studies in Still's disease. Juvenile chronic polyarthritis. Rheumatology1969;2:37–61.
  • Lindsley CB. Seasonal variation in systemic onset juvenile rheumatoid arthritis. Arthritis Rheum1987;30(7):838–839.
  • Murray K, Thompson SD, Glass DN. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child 1997;77(6):530–534.
  • Lehmann HW, Knöll A, Küster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 2003;48(6):1631–1638.
  • Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep 2020;69(40):1450–1456.
  • Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34(33):2636–2648, 2648a–2648d.
  • Stewart GC, Lopez-Molina J, Gottumukkala RVSRK, Rosner GF, Anello MS, Hecht JL, et al. Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail 2011;4(1):71–78.
  • Nielsen TS, Hansen J, Nielsen LP, Baandrup UT, Banner J. The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts. Forensic Sci Med Pathol 2014;10(3):344–350.
  • Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19(3):424–430.

    • Views: 539
    HTML downloads: 107
    PDF downloads: 262

    Published: 2022-01-28
    Issue: 2022: Vol 9 No 1 (view)

    How to cite:
    1.
    Altuzarra-Ranedo Y, Gómez-Ramírez D, Rodríguez-Laguna M, Lois-Bermejo PM, López-Pelaez B, Lorenzo-Villalba N, Méndez-Bailón M. Parvovirus Infection Triggering Still’s Disease. EJCRIM 2022;9 doi:10.12890/2022_003122.

    Most read articles by the same author(s)